学术探索
学术期刊
新闻热点
数据分析
智能评审

Genetic and epigenetic regulation of human breast cancer progression and metastasis

被引：28
作者：
Welch, DR
Wei, LL
机构：
[1] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Jake Gittlen Canc Res Inst, Hershey, PA 17033 USA
[2] Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Lombardi Canc Ctr, Washington, DC 20007 USA
来源：
ENDOCRINE-RELATED CANCER | 1998年 / 5卷 / 03期
关键词：
D O I：
10.1677/erc.0.0050155
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：155 / 197
页数：43
相关论文
共 595 条
[1]  
ADNANE J, 1991, ONCOGENE, V6, P659
[2]   THE ROLE OF POLYMORPHONUCLEAR LEUKOCYTES (PMN) ON THE GROWTH AND METASTATIC POTENTIAL OF 13762NF MAMMARY ADENOCARCINOMA CELLS [J].
AEED, PA ;
NAKAJIMA, M ;
WELCH, DR .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (05) :748-759
[3]   Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer [J].
Afify, A ;
Bland, KI ;
Mark, HFL .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 38 (02) :201-208
[4]  
AGARWAL C, 1994, CANCER RES, V54, P943
[5]   Thrombospondin-1 and transforming growth factor-beta1 promote breast tumor cell invasion through upregulation of the plasminogen/plasmin system [J].
Albo, D ;
Berger, DH ;
Wang, TN ;
Hu, XL ;
Rothman, V ;
Tuszynski, GP .
SURGERY, 1997, 122 (02) :493-499
[6]   REDUCTION TO HOMOZYGOSITY OF GENES ON CHROMOSOME-11 IN HUMAN-BREAST NEOPLASIA [J].
ALI, IU ;
LIDEREAU, R ;
THEILLET, C ;
CALLAHAN, R .
SCIENCE, 1987, 238 (4824) :185-188
[7]   OVEREXPRESSION OF HER-2 NEU AND ITS RELATIONSHIP WITH OTHER PROGNOSTIC FACTORS CHANGE DURING THE PROGRESSION OF INSITU TO INVASIVE BREAST-CANCER [J].
ALLRED, DC ;
CLARK, GM ;
MOLINA, R ;
TANDON, AK ;
SCHNITT, SJ ;
GILCHRIST, KW ;
OSBORNE, CK ;
TORMEY, DC ;
MCGUIRE, WL .
HUMAN PATHOLOGY, 1992, 23 (09) :974-979
[8]   ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER [J].
ALLRED, DC ;
CLARK, GM ;
ELLEDGE, R ;
FUQUA, SAW ;
BROWN, RW ;
CHAMNESS, GC ;
OSBORNE, CK ;
MCGUIRE, WL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) :200-206
[9]  
*AM CANC SOC, 1998, CA-CANCER J CLIN, V48, P1
[10]  
Amundadottir LT, 1996, ONCOGENE, V13, P757
12345678910